AtherOx

Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease

DENVER--(BUSINESS WIRE)--Jul 10, 2007 - Corgenix Medical Corporation (OTC BB: CONX) and the Company's clinical collaborators reported new clinical data demonstrating a significant correlation between serum levels of the Company's patented AtherOx(TM) bio-markers and cardiovascular disease. The data...

AtherOx in Biological Technology

Corgenix Receives Two Additional Patents on AtherOx(R) Technology

...the components and assay procedure used to measure atherox complexes in biological samples. The latest p...DL/B2GPI complexes which is the basis for Corgenix atherox test kits. Douglass Simpson, President and CE...ortant additions to our IP portfolio. We have one atherox related product already cleared by the FDA and sev...

Corgenix Announces FDA Clearance for IgG Anti-AtherOx(R) Test Kit

...ith important autoimmune diseases. Research data presented at several medical and scientific meetings has shown the association of antibodies to the atherox (R) complex with vascular thrombosis (particularly arterial thrombosis) in patients with autoimmune diseases. Studies published in The Journal of Clin...